[Federal Register Volume 87, Number 199 (Monday, October 17, 2022)]
[Notices]
[Page 62861]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22486]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines Meeting

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Advisory Commission on Childhood Vaccines (ACCV) provides 
advice and recommendations to the Secretary of HHS (Secretary) on 
policy, program development, and other issues related to the 
implementation of the National Vaccine Injury Compensation Program 
(VICP) and concerning other matters as described under the Public 
Health Service Act. To ensure compliance with the statutory requirement 
that the ACCV meet not less than four times per year, this notice 
announces that the ACCV meeting originally scheduled for March 3, 2022, 
has been rescheduled for December 2, 2022.

DATES: The ACCV meeting will be held on December 2, 2022, from 1:00 
p.m.-4:00 p.m. Eastern Time.

ADDRESSES: This meeting will be held by Zoom webinar.
     Webinar link: https://hrsa-gov.zoomgov.com/j/1603695024?pwd=ZG4rUWw0NUlTN2d0OWRZWVJjVmNIZz09.
     Conference call-in number: 833 568 8864, Meeting ID: 160 
369 5024, Passcode: 72471327.

FOR FURTHER INFORMATION CONTACT: Pita Gomez, Principal Staff Liaison, 
ACCV, 5600 Fishers Lane, Rockville, Maryland 20857, telephone: (301) 
945-9386 or email: [email protected].

SUPPLEMENTARY INFORMATION: All 2022 ACCV meetings were originally 
announced in the Federal Register, Vol. 87, No. 20 on Monday, January 
31, 2022, (FR Doc. 2022-01848 Filed 1-28-22), and the notice canceling 
the March 3, 2022, meeting was published on February 28, 2022 (FR Doc. 
2022-04127 Filed 2-25-22).
    Since priorities dictate ACCV meeting times, be advised that start 
times, end times, and agenda items are subject to change. Agenda items 
may include but are not limited to, updates from the Division of Injury 
Compensation Programs (HRSA), Torts Branch (Department of Justice), 
Office of Infectious Disease and HIV/AIDS Policy (HHS), Immunization 
Safety Office (Centers for Disease Control and Prevention), National 
Institute of Allergy and Infectious Diseases (National Institutes of 
Health) and Center for Biologics, Evaluation and Research (Food and 
Drug Administration). Refer to the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/index.html for all current 
and updated information concerning the ACCV meeting, including draft 
agendas and meeting materials that will be posted 5 calendar days 
before the meeting.
    The ACCV meeting will be public, and members of the public will 
have the opportunity to provide comments. Public participants may 
submit written statements in advance of the scheduled meeting. Oral 
comments will be honored in the order they are requested and may be 
limited as time allows. Requests to submit a written statement or make 
oral comments to the ACCV should be sent to Pita Gomez using the 
contact information above at least 5 business days before the meeting 
date.
    Individuals who need special assistance or another reasonable 
accommodation should notify Pita Gomez using the contact information 
listed above at least 10 business days before the meeting they wish to 
attend.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-22486 Filed 10-14-22; 8:45 am]
BILLING CODE 4165-15-P